…population. Taken as a twice-daily pill, abemaciclib works by targeting and inhibiting proteins in cancer cells which allow the cancer to divide and grow. NICE’s recommendation was based on data…

…against serious infections. The treatment used in the study from TAU involves an injection of genetically engineered type B white blood cells into a patient’s body, catalysing the immune system…

Culturing cells in 3D is simply a more realistic way to model how cells move and function in vitro. Spheroids, organoids, and more complex 3D systems have been invaluable to…

Culturing cells in 3D is simply a more realistic way to model how cells move and function in vitro. Spheroids, organoids, and more complex 3D systems have been invaluable to…

…(DLBCL). DLBCL is an aggressive, fast-growing blood cancer that develops from B-cells in the lymphatic system and which is the most common subtype of non-Hodgkin lymphoma. Treatment for DLBCL is…

Life sciences provider Axol Bioscience has announced that its human induced pluripotent stem cell (iPSC)-derived ventricular cardiomyocytes have undergone comprehensive in vitropro-arrhythmia assay (CiPA) validation. By using this assay, Axol…

…cells in your blood, causing the immune system to become weakened. Of these cases, 10% were life threatening. In the ZUMA-3 cohort, a fatal Grade 5 AE has occurred since…

…cells like primary T cells (Figure 3), consider an electroporation delivery approach. Figure 3 FIGURE 3. The Ingenio® Electroporation System Balances Efficiency and Viability. Primary human T cells were electroporated…

…delivering nucleic acid cargo into mammalian and insect cells: chemical transfection, viral transduction, and electroporation. This listicle highlights and when to use, the benefits of each approach. Click here to…

…and CRS is one the most frequent and serious side-effects of the treatment. CRS can lead to widespread organ dysfunction and is common in patients treated by infused CAR-T cells….